Targeted agent blocked growth of deadly brain cancer in preclinical studies

A drug already in clinical trials to treat a variety of tumours shows a remarkable ability to shut down growth of glioblastoma in both laboratory cells and in animals, say researchers from Georgetown Lombardi Comprehensive Cancer Centre and the University of California, San Francisco (UCSF). In their experiments, the agent put a brake on growth of laboratory cancer cell lines, and no mice with glioblastoma in their brain died as a result of their tumour while on therapy...

Read the whole article on

More from